摘要
过敏性疾病是21世纪重点防治的3大疾病之一,目前仍无有效方法对患者达到治愈的目的.特异性免疫治疗(SIT)是针对过敏性疾病唯一的对因治疗方法,传统的SIT具有很大的副作用,开发低致敏原疫苗将对SIT的安全性方面有着十分重要的意义.
Hypersensitivity disease is one of the three key prevention diseases in 21 century. Currently, it has no effective method for radical treatment. Specific immunotherapy is the only way to cure type I hypersensitivity disease thoroughgoingly. However, traditional specific immunotherapy has tremendous side-effects. Therefore, exploitation hypoallergenic derivatives vaccines will play an important role for safer specific immunotherapy.
出处
《江西师范大学学报(自然科学版)》
CAS
北大核心
2011年第4期353-357,共5页
Journal of Jiangxi Normal University(Natural Science Edition)
基金
国家自然科学基金(30871752)
深圳市科技计划三新重点项目(200902)
深圳大学创新团队基金(200904)资助项目